Clinical Trials
3 trialsNCT00818480 2015-09-04
An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155
Astellas Pharma Inc
Phase 2 Completed
NCT01009775 2015-09-04
A Study of YM155 Plus Docetaxel in Subjects With Stage III (Unresectable) or Stage IV Melanoma
Astellas Pharma Inc
Phase 2 Completed
NCT00281541 2012-06-07
A Study for the Treatment of Unresectable Stage III or Metastatic Stage IV Melanoma
Astellas Pharma Inc
Phase 2 Completed